1. Risk factors of severe COVID-19 in people with multiple sclerosis : a systematic review and meta-analysis;Etemadifar;Rev. Neurol. (Paris),2021
2. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies;Sormani;EBioMedicine,2021
3. COVID-19 vaccine response in people with multiple sclerosis;Tallantyre;Ann. Neurol.,2021
4. Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity;Sabatino;medRxiv,2021
5. Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines;Madelon;medRxiv,2021